Gwen A Melincoff
CIK 1614890 · last filed 2026-07-17
Gwen A Melincoff is a corporate insider who has filed 32 SEC Form 4 insider transactions across 7 companies since 2015. The most recent filing, for GANX, was dated Jul 17, 2026. Across all open-market trades the lifetime net is +$15.4K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.92M
7
32
$15.4K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GANX | Director | — | $1.73 | — | $0 | 5 | 2026-07-17 |
| PLX | Director | 7,500 | $2.33 | $17.5K | $0 | 4 | 2025-09-04 |
| COLL | Director | 52,468 | $35.90 | $1.88M | $0 | 5 | 2024-05-16 |
| SOLENO THERAPEUTICS INC (SLNO) Delisted | Director | 666 | $53.01 | $35.3K | $15.4K | 7 | 2023-05-26 |
| SOLENO THERAPEUTICS INC (SLNOW) Delisted | Director | — | — | — | $0 | 2 | 2019-06-12 |
| ESPR | Director | 6,960 | $3.18 | $22.1K | $0 | 3 | 2019-04-29 |
| Tobira Therapeutics, Inc. (TBRA) Delisted | Director | — | — | — | $0 | 3 | 2016-01-14 |
Recent Filings
32 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-17 | GANX | Grant (A) | — | $0 | EDGAR |
| 2025-09-04 | PLX | Grant (A) | +7,500 | $0 | EDGAR |
| 2025-07-02 | COLL | Notice (144) | −47,082 | -$1.43M | EDGAR |
| 2025-06-25 | GANX | Grant (A) | — | $0 | EDGAR |
| 2024-06-28 | SOLENO THERAPEUTICS INC (SLNO) Delisted | Notice (144) | −12,666 | -$506.6K | EDGAR |
| 2024-06-26 | GANX | Grant (A) | — | $0 | EDGAR |
| 2024-05-16 | COLL | Grant (A) | +7,693 | $0 | EDGAR |
| 2023-10-03 | PLX | Grant (A) | — | $0 | EDGAR |
| 2023-06-26 | GANX | Grant (A) | — | $0 | EDGAR |
| 2023-05-26 | SOLENO THERAPEUTICS INC (SLNO) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.